Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
- Citation:
- Br J Haematol vol 199 (3) 355-65
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3640
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Douglas W. Sborov Muhamed Baljevic Brandi Reeves Jacob Laubach Yvonne A. Efebera Cesar Rodriguez Luciano J. Costa Ajai Chari Rebecca Silbermann Sarah A. Holstein Larry D. Anderson Jr Jonathan L. Kaufman Nina Shah Huiling Pei Sharmila Patel Annelore Cortoos J. Blake Bartlett Jessica Vermeulen Thomas S. Lin Peter M. Voorhees Paul G. Richardson
- Networks:
- Study
- AFT-29 (GRIFFIN)
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: